Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

INTRODUCTION: Targeting HER2 has improved outcomes in metastatic GE (mGE) cancer. In this study, we aim to explore the feasibility of molecular profiling in patients with refractory mGE cancer in routine clinical practice. METHODS: Archival formalin-fixed, paraffin-embedded (FFPE) samples for patien...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Mikhail, Sameh, Ciombor, Kristen, Noonan, Anne, Wu, Christina, Goldberg, Richard, Zhao, Weiqiang, Wei, Lai, Mathey, Kristina, Yereb, Melissa, Timmers, Cynthia, Bekaii-Saab, Tanios
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2015
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673157/
https://ncbi.nlm.nih.gov/pubmed/26082439
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg